Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311474A1 Sulfonamide derivatives
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1311471A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311300A1 Radioligand and binding assay
05/21/2003EP1311299A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311296A2 Solution of an oxazolidinone antibiotic drug
05/21/2003EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
05/21/2003EP1311294A2 Formulations of mometasone and a bronchodilator for pulmonary administration
05/21/2003EP1311293A2 Combinations of ssri and estrogenic agents
05/21/2003EP1311292A2 Vitronectin receptor antagonist pharmaceuticals
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311279A1 Treatment of hepatitis c with thymosin, interferon and ribavirin
05/21/2003EP1311277A1 Methods of modulating fibrosis
05/21/2003EP1311276A1 Methods of preventing or treating diseases and conditions using complex carbohydrates
05/21/2003EP1311275A1 A synthetic bulk laxative
05/21/2003EP1311274A1 New use
05/21/2003EP1311273A2 Combination of a purine and an nsaid for treating sexual dysfunction
05/21/2003EP1311272A1 Novel methods using cholinesterase inhibitors
05/21/2003EP1311271A1 Use of triazinetrione sulfoxides for controlling coccidioses
05/21/2003EP1311270A1 Non-sedating barbiturate compounds as neuroprotective agents
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311268A1 Imidazopyridine and imidazopyrimidine antiviral agents
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311266A2 Combination hiv therapy including camptothecin
05/21/2003EP1311265A2 Pharmaceutical compositions for treating neurological disorders
05/21/2003EP1311264A1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311262A1 Cancer treatment by combination therapy
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1311260A2 Lipase inhibitors to treat dyspepsia
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311258A2 Compositions containing hypotriglyceridemically active stilbenoids
05/21/2003EP1311256A2 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311254A2 METHODS FOR TREATING SUBJECTS INFECTED WITH A HERPES VIRUS OR i NEISSERIA GONORRHEAE /i
05/21/2003EP1311253A2 Use of vitamin d derivatives as bone resorption inhibitors
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1311251A2 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
05/21/2003EP1311249A1 Transdermal therapeutic system
05/21/2003EP1311248A1 Transdermal therapeutic system for treating restless-legs-syndrome
05/21/2003EP1311244A2 Steroid hormones as transfer agents
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1311238A2 Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols
05/21/2003EP1311237A2 Use of cyclic 2,4-diphosphoglycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations
05/21/2003EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
05/21/2003EP1311213A1 Vaginal delivery of bisphosphonates
05/21/2003EP1311202A1 Method and system for anticoagulant dose revision
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1263979A4 Method of purifying a fermentation broth
05/21/2003EP1244444A4 Process for formulation of carbapenem antibiotic compositions
05/21/2003EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same
05/21/2003EP1200066B1 Aqueous nasal formulation
05/21/2003EP1192450A4 High energy phototherapeutic agents
05/21/2003EP1192161B1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
05/21/2003EP1189585B1 Cosmetic skin care compositions containing cumic alcohol
05/21/2003EP1186607B1 Optically active pyrrolopyridazine compounds
05/21/2003EP1173439B1 Haloalkoxy imidazonaphthyridines
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1142578B1 Method for producing an antitumoral agent and antitumoral agent thus obtained
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1091970B1 Method for preparing aloin by extraction
05/21/2003EP1047668B1 Triazepinones, process for their preparation and their therapeutic application
05/21/2003EP1039802B1 Transdermal therapeutic device with capsaicin and capsaicin analogs
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP1014985B1 A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist
05/21/2003EP1009732B1 1-amino-alkylcyclohexane nmda receptor antagonists
05/21/2003EP1005369B1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
05/21/2003EP0991616B1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
05/21/2003EP0988042A4 A combination therapy for hiv infections
05/21/2003EP0981348B1 The use of levobupivacaine in paediatric surgery
05/21/2003EP0981347B1 The use of levobupivacaine in facial surgery
05/21/2003EP0981334B1 Swallow tablet comprising paracetamol
05/21/2003EP0969744B1 Nutritional composition for improvements in cell energetics
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003EP0942919B1 Sulphatase Inhibitors
05/21/2003EP0927027B1 Use of 5-ht 4? antagonists for regulating corticosteroid secretion
05/21/2003EP0923581B1 4-substituted beta-carbolines as immunomodulators
05/21/2003EP0915895B1 New salts of anionic complexes of ru(iii), as antimetastatic and antineoplastic agents
05/21/2003EP0907646B1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
05/21/2003EP0888111B1 Modified release multiple-units dosage composition
05/21/2003EP0876613B1 Treatment and diagnosis of infections due to helicobacter pylori
05/21/2003EP0874827B1 Quinoline derivatives as nk3 antagonists
05/21/2003EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/21/2003EP0871453B1 Combined hormonal contraception pharmaceutical preparation
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003EP0845939B1 Lysosomal proteins produced in the milk of nonhuman transgenic animals
05/21/2003EP0842658B1 Photostable aqueous solution containing benzyl alcohol derivatives
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0835118B1 Utilization of sophorolipids for the preparation of cosmetic products, in particular for the treatment of the skin
1 ... 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 ... 7860